معرفی
Michael Levin is a Professor of Paediatrics and International Child Health at Imperial College London's Faculty of Medicine. He leads research in infectious disease diagnosis/treatment, particularly in meningococcal disease, tuberculosis, and Kawasaki disease. Key roles include EU-funded DIAMONDS project (€22.5M) for rapid infection diagnostics and PERFORM study on RNA transcriptomics. Clinically, he works as a paediatric infectious diseases consultant.
Education: MBChB from University of Witwatersrand (1975), PhD from University of London (1990). Professional memberships include Fellow of the Academy of Medical Sciences (FMedSci) and Royal College of Physicians (FRCP). Awards include MBE (2017) for contributions to paediatric infectious disease research.
Research focuses on: 1) Host-response biomarkers for bacterial/viral infections, 2) Kawasaki disease genetics, 3) Tuberculosis diagnostics, 4) Sepsis criteria development. His labs have pioneered RNA-based diagnostic systems using transcriptomic profiling.
Recent articles highlight work on pediatric sepsis criteria (JAMA 2024), MIS-C biomarkers (Nature Medicine 2023), and Omicron variant long-COVID outcomes (Lancet 2023). He collaborates globally on projects like the Phoenix criteria validation and EU-funded biomarker studies.
Awards: MBE (2017), FMedSci (1998), €22.5M EU grant (2020). Active in clinical trials and diagnostic tool development, with over 3,800 publications indexed in PubMed. Supervises research teams focused on translational medicine and global child health challenges.